Cardiol Therapeutics is a biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases. The company is dedicated to advancing the treatment of heart conditions by leveraging its proprietary formulations and research into the therapeutic potential of cannabidiol, a compound derived from cannabis. Through rigorous scientific investigation and clinical trials, Cardiol aims to produce effective solutions that can improve quality of life for patients suffering from various heart-related ailments, with a vision of making significant contributions to the field of cardiology.